Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report)‘s stock had its “market outperform” rating reiterated by equities researchers at JMP Securities in a research note issued on Friday, Benzinga reports. They presently have a $22.00 target price on the biotechnology company’s stock. JMP Securities’ price target would indicate a potential upside of 118.91% from the stock’s […]

Unum Group (NYSE:UNM – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Piper Sandler in a research note issued on Friday, Benzinga reports. They presently have a $66.00 target price on the financial services provider’s stock, up from their prior target price of $64.00. Piper Sandler’s target price would […]

Stock analysts at Royal Bank of Canada initiated coverage on shares of Nasdaq (NASDAQ:NDAQ – Get Free Report) in a research note issued to investors on Friday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $88.00 price target on the financial services provider’s stock. Royal Bank of Canada’s price target points to […]

Research analysts at StockNews.com began coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a note issued to investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other equities analysts have also commented on the company. Oppenheimer lowered their price objective on Cellectis from $11.00 […]